Oncomine assay developed by thermofisher：Targeted Next

FDA Clears Thermo Fisher Scientific Oncomine Assay as ...

https://www.precisionmedicineo

The FDA first approved the test as a CDx in 2017, and it is now approved for four targeted therapies for non-small cell lung cancer and one ...

Geneuity Adopts Thermo Fisher's Oncomine Assay

https://www.technologynetworks

Based on Thermo Fisher's Ion AmpliSeq technology, the assay allows detection of single nucleotide somatic changes, inversions, insertions and ...

Genexus Oncology

https://www.oncomine.com

The only true end to end NGS solution for oncology biomarker profiling in clinical research: Ion Torrent Genexus System by Thermo Fisher Scientific.

Oncomine Assays for Oncology Research

https://www.thermofisher.com

Oncomine assays are multi-biomarker targeted NGS assays designed for cancer research. Analysis of multiple biomarker types—fusions, insertion/deletions ...

Oncomine Comprehensive Assay

https://www.thermofisher.com

Thermo Fisher Scientific Expands Oncomine Portfolio for ...

https://www.labmanager.com

– (January 8, 2018) – Thermo Fisher Scientific has expanded its Oncomine portfolio with new assays for liquid biopsy and immuno-oncology to ...

Thermo Fisher Scientific Signs New Agreements to Expand ...

https://www.prnewswire.com

Expansion of Oncomine Dx Target Test aligns with the company's strategic plan to further develop its test as a companion diagnostic (CDx) for ...

Thermo Fisher's Oncomine Dx Target Test

https://thepathologist.com

Thermo Fisher Scientific's Jane Li explains the ever-developing tale of companion diagnostic tests in precision oncology.

Thermo Fisher's Oncomine Precision Assay granted ...

https://www.bioanalysis-zone.c

FDA grants Breakthrough Device Designation to Thermo Fisher's assay for identifying low-grade glioma patients eligible for vorasidenib.